Eli Lilly and Company (LLY)
NYSE: LLY · IEX Real-Time Price · USD
733.51
+8.64 (1.19%)
At close: Apr 26, 2024, 4:00 PM
733.50
-0.01 (0.00%)
After-hours: Apr 26, 2024, 7:59 PM EDT
Eli Lilly Revenue
In the year 2023, Eli Lilly had annual revenue of $34.12B with 19.56% growth. Revenue in the quarter ending December 31, 2023 was $9.35B with 28.10% year-over-year growth.
Revenue (ttm)
$34.12B
Revenue Growth
+19.56%
P/S Ratio
20.44
Revenue / Employee
$793,584
Employees
43,000
Market Cap
697.40B USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 34.12B | 5.58B | 19.56% |
Dec 31, 2022 | 28.54B | 223.00M | 0.79% |
Dec 31, 2021 | 28.32B | 3.78B | 15.40% |
Dec 31, 2020 | 24.54B | 2.22B | 9.95% |
Dec 31, 2019 | 22.32B | 826.20M | 3.84% |
Dec 31, 2018 | 21.49B | 1.52B | 7.61% |
Dec 31, 2017 | 19.97B | -1.25B | -5.88% |
Dec 31, 2016 | 21.22B | 1.26B | 6.33% |
Dec 31, 2015 | 19.96B | 343.10M | 1.75% |
Dec 31, 2014 | 19.62B | -3.50B | -15.13% |
Dec 31, 2013 | 23.11B | 509.70M | 2.25% |
Dec 31, 2012 | 22.60B | -1.68B | -6.93% |
Dec 31, 2011 | 24.29B | 1.21B | 5.25% |
Dec 31, 2010 | 23.08B | 1.24B | 5.68% |
Dec 31, 2009 | 21.84B | 1.46B | 7.19% |
Dec 31, 2008 | 20.37B | 1.74B | 9.33% |
Dec 31, 2007 | 18.63B | 2.94B | 18.75% |
Dec 31, 2006 | 15.69B | 1.05B | 7.14% |
Dec 31, 2005 | 14.65B | 787.40M | 5.68% |
Dec 31, 2004 | 13.86B | 1.28B | 10.14% |
Dec 31, 2003 | 12.58B | 1.51B | 13.59% |
Dec 31, 2002 | 11.08B | -465.00M | -4.03% |
Dec 31, 2001 | 11.54B | 680.30M | 6.26% |
Dec 31, 2000 | 10.86B | 859.30M | 8.59% |
Dec 31, 1999 | 10.00B | 766.10M | 8.29% |
Dec 31, 1998 | 9.24B | 1.25B | 15.64% |
Dec 31, 1997 | 7.99B | 989.40M | 14.14% |
Dec 31, 1996 | 7.00B | 234.50M | 3.47% |
Dec 31, 1995 | 6.76B | 1.05B | 18.42% |
Dec 31, 1994 | 5.71B | 513.10M | 9.87% |
Dec 31, 1993 | 5.20B | 235.40M | 4.74% |
Dec 31, 1992 | 4.96B | -762.60M | -13.32% |
Dec 31, 1991 | 5.73B | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 371.62B |
Johnson & Johnson | 85.16B |
Merck & Co. | 60.12B |
AbbVie | 54.32B |
Novartis AG | 49.92B |
AstraZeneca | 47.61B |
Thermo Fisher | 42.86B |
Abbott Laboratories | 40.11B |
LLY News
- 11 hours ago - Cramer's week ahead: Fed meeting and earnings from Apple, Amazon, Eli Lilly - CNBC
- 12 hours ago - What You Need To Know Ahead of Eli Lilly's Earnings Report Tuesday - Investopedia
- 20 hours ago - A 3x Expected Rise In Mounjaro Sales Is Likely To Drive Eli Lilly's Q1 - Forbes
- 4 days ago - Hagens Berman Signals Major Turning Point in Insulin Fair Pricing Class-Action Lawsuit - Business Wire
- 4 days ago - Eli Lilly to acquire manufacturing facility from Nexus Pharma - Reuters
- 9 days ago - Eli Lilly's Weight-Loss Treatment Found To Help Those With Sleep Apnea - Investopedia
- 9 days ago - Most doses of Eli Lilly's Zepbound, Mounjaro in short supply through June, FDA says - CNBC
- 9 days ago - Eli Lilly's weight-loss drug Zepbound might help cure your sleep apnea - Fast Company